Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Anchora Medical's primary focus?
- Anchora Medical develops minimally invasive suturing devices for endoscopic (GI) and laparoscopic (hernia) procedures, utilizing sterile, automatic, single-use devices with stainless steel or nitinol anchors.
- When was Anchora Medical founded?
- Anchora Medical was founded in October 2014.
- What was Anchora Medical's first product to receive FDA clearance?
- In July 2021, Anchora Medical received FDA clearance for its first product, the Su2ura Approximation Device, which is currently in clinical use.
- What was the most recent funding round for Anchora Medical?
- Anchora Medical completed an Undisclosed round in July 2024, with Katao Venture Partners as a lead investor.
- Which investors participated in Anchora Medical's Series B funding round?
- In February 2020, Anchora Medical closed a Series B round led by Hoya Corporation, with participation from Alon MedTech Ventures, Tal Ventures, and Dr. Shimon Eckhouse.
- What is the total amount of funding Anchora Medical has raised?
- Anchora Medical has raised a total of $5.2 million USD. For a full financing history, please refer to startupim.
- How many employees does Anchora Medical currently have?
- Anchora Medical currently has 5 employees.
- Where is Anchora Medical's headquarters located?
- Anchora Medical's headquarters is located in Caesarea, Israel.
- Which markets does Anchora Medical target geographically?
- Anchora Medical targets the United States, Europe, and Israel as its geographic markets.